IBDEI2L3 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41238,2)
;;=^5138332
;;^UTILITY(U,$J,358.3,41239,0)
;;=E11.3213^^152^2030^24
;;^UTILITY(U,$J,358.3,41239,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41239,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
;;^UTILITY(U,$J,358.3,41239,1,4,0)
;;=4^E11.3213
;;^UTILITY(U,$J,358.3,41239,2)
;;=^5138333
;;^UTILITY(U,$J,358.3,41240,0)
;;=E11.40^^152^2030^10
;;^UTILITY(U,$J,358.3,41240,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41240,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,41240,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,41240,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,41241,0)
;;=E11.51^^152^2030^12
;;^UTILITY(U,$J,358.3,41241,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41241,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,41241,1,4,0)
;;=4^E11.51
;;^UTILITY(U,$J,358.3,41241,2)
;;=^5002650
;;^UTILITY(U,$J,358.3,41242,0)
;;=E11.52^^152^2030^11
;;^UTILITY(U,$J,358.3,41242,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41242,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,41242,1,4,0)
;;=4^E11.52
;;^UTILITY(U,$J,358.3,41242,2)
;;=^5002651
;;^UTILITY(U,$J,358.3,41243,0)
;;=E11.620^^152^2030^5
;;^UTILITY(U,$J,358.3,41243,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41243,1,3,0)
;;=3^DM Type 2 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,41243,1,4,0)
;;=4^E11.620
;;^UTILITY(U,$J,358.3,41243,2)
;;=^5002655
;;^UTILITY(U,$J,358.3,41244,0)
;;=E11.36^^152^2030^4
;;^UTILITY(U,$J,358.3,41244,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41244,1,3,0)
;;=3^DM Type 2 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,41244,1,4,0)
;;=4^E11.36
;;^UTILITY(U,$J,358.3,41244,2)
;;=^5002642
;;^UTILITY(U,$J,358.3,41245,0)
;;=I10.^^152^2031^1
;;^UTILITY(U,$J,358.3,41245,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41245,1,3,0)
;;=3^Essential/Primary Hypertension
;;^UTILITY(U,$J,358.3,41245,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,41245,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,41246,0)
;;=I11.0^^152^2031^12
;;^UTILITY(U,$J,358.3,41246,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41246,1,3,0)
;;=3^Hypertensive Heart Disease w/ Heart Failure
;;^UTILITY(U,$J,358.3,41246,1,4,0)
;;=4^I11.0
;;^UTILITY(U,$J,358.3,41246,2)
;;=^5007063
;;^UTILITY(U,$J,358.3,41247,0)
;;=I11.9^^152^2031^13
;;^UTILITY(U,$J,358.3,41247,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41247,1,3,0)
;;=3^Hypertensive Heart Disease w/o Heart Failure
;;^UTILITY(U,$J,358.3,41247,1,4,0)
;;=4^I11.9
;;^UTILITY(U,$J,358.3,41247,2)
;;=^5007064
;;^UTILITY(U,$J,358.3,41248,0)
;;=I12.0^^152^2031^5
;;^UTILITY(U,$J,358.3,41248,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41248,1,3,0)
;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
;;^UTILITY(U,$J,358.3,41248,1,4,0)
;;=4^I12.0
;;^UTILITY(U,$J,358.3,41248,2)
;;=^5007065
;;^UTILITY(U,$J,358.3,41249,0)
;;=I12.9^^152^2031^4
;;^UTILITY(U,$J,358.3,41249,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41249,1,3,0)
;;=3^Hypertensive CKD w/ Stage 1-4 CKD
;;^UTILITY(U,$J,358.3,41249,1,4,0)
;;=4^I12.9
;;^UTILITY(U,$J,358.3,41249,2)
;;=^5007066
;;^UTILITY(U,$J,358.3,41250,0)
;;=I13.0^^152^2031^8
;;^UTILITY(U,$J,358.3,41250,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41250,1,3,0)
;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
;;^UTILITY(U,$J,358.3,41250,1,4,0)
;;=4^I13.0
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2L3 3774 printed Apr 09, 2024@21:40:23 Page 2
IBDEI2L3 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41238,2)
+2 ;;=^5138332
+3 ;;^UTILITY(U,$J,358.3,41239,0)
+4 ;;=E11.3213^^152^2030^24
+5 ;;^UTILITY(U,$J,358.3,41239,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,41239,1,3,0)
+8 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
+9 ;;^UTILITY(U,$J,358.3,41239,1,4,0)
+10 ;;=4^E11.3213
+11 ;;^UTILITY(U,$J,358.3,41239,2)
+12 ;;=^5138333
+13 ;;^UTILITY(U,$J,358.3,41240,0)
+14 ;;=E11.40^^152^2030^10
+15 ;;^UTILITY(U,$J,358.3,41240,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,41240,1,3,0)
+18 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
+19 ;;^UTILITY(U,$J,358.3,41240,1,4,0)
+20 ;;=4^E11.40
+21 ;;^UTILITY(U,$J,358.3,41240,2)
+22 ;;=^5002644
+23 ;;^UTILITY(U,$J,358.3,41241,0)
+24 ;;=E11.51^^152^2030^12
+25 ;;^UTILITY(U,$J,358.3,41241,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,41241,1,3,0)
+28 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
+29 ;;^UTILITY(U,$J,358.3,41241,1,4,0)
+30 ;;=4^E11.51
+31 ;;^UTILITY(U,$J,358.3,41241,2)
+32 ;;=^5002650
+33 ;;^UTILITY(U,$J,358.3,41242,0)
+34 ;;=E11.52^^152^2030^11
+35 ;;^UTILITY(U,$J,358.3,41242,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,41242,1,3,0)
+38 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
+39 ;;^UTILITY(U,$J,358.3,41242,1,4,0)
+40 ;;=4^E11.52
+41 ;;^UTILITY(U,$J,358.3,41242,2)
+42 ;;=^5002651
+43 ;;^UTILITY(U,$J,358.3,41243,0)
+44 ;;=E11.620^^152^2030^5
+45 ;;^UTILITY(U,$J,358.3,41243,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,41243,1,3,0)
+48 ;;=3^DM Type 2 w/ Diab Dermatitis
+49 ;;^UTILITY(U,$J,358.3,41243,1,4,0)
+50 ;;=4^E11.620
+51 ;;^UTILITY(U,$J,358.3,41243,2)
+52 ;;=^5002655
+53 ;;^UTILITY(U,$J,358.3,41244,0)
+54 ;;=E11.36^^152^2030^4
+55 ;;^UTILITY(U,$J,358.3,41244,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,41244,1,3,0)
+58 ;;=3^DM Type 2 w/ Diab Cataract
+59 ;;^UTILITY(U,$J,358.3,41244,1,4,0)
+60 ;;=4^E11.36
+61 ;;^UTILITY(U,$J,358.3,41244,2)
+62 ;;=^5002642
+63 ;;^UTILITY(U,$J,358.3,41245,0)
+64 ;;=I10.^^152^2031^1
+65 ;;^UTILITY(U,$J,358.3,41245,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,41245,1,3,0)
+68 ;;=3^Essential/Primary Hypertension
+69 ;;^UTILITY(U,$J,358.3,41245,1,4,0)
+70 ;;=4^I10.
+71 ;;^UTILITY(U,$J,358.3,41245,2)
+72 ;;=^5007062
+73 ;;^UTILITY(U,$J,358.3,41246,0)
+74 ;;=I11.0^^152^2031^12
+75 ;;^UTILITY(U,$J,358.3,41246,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,41246,1,3,0)
+78 ;;=3^Hypertensive Heart Disease w/ Heart Failure
+79 ;;^UTILITY(U,$J,358.3,41246,1,4,0)
+80 ;;=4^I11.0
+81 ;;^UTILITY(U,$J,358.3,41246,2)
+82 ;;=^5007063
+83 ;;^UTILITY(U,$J,358.3,41247,0)
+84 ;;=I11.9^^152^2031^13
+85 ;;^UTILITY(U,$J,358.3,41247,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,41247,1,3,0)
+88 ;;=3^Hypertensive Heart Disease w/o Heart Failure
+89 ;;^UTILITY(U,$J,358.3,41247,1,4,0)
+90 ;;=4^I11.9
+91 ;;^UTILITY(U,$J,358.3,41247,2)
+92 ;;=^5007064
+93 ;;^UTILITY(U,$J,358.3,41248,0)
+94 ;;=I12.0^^152^2031^5
+95 ;;^UTILITY(U,$J,358.3,41248,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,41248,1,3,0)
+98 ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
+99 ;;^UTILITY(U,$J,358.3,41248,1,4,0)
+100 ;;=4^I12.0
+101 ;;^UTILITY(U,$J,358.3,41248,2)
+102 ;;=^5007065
+103 ;;^UTILITY(U,$J,358.3,41249,0)
+104 ;;=I12.9^^152^2031^4
+105 ;;^UTILITY(U,$J,358.3,41249,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,41249,1,3,0)
+108 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
+109 ;;^UTILITY(U,$J,358.3,41249,1,4,0)
+110 ;;=4^I12.9
+111 ;;^UTILITY(U,$J,358.3,41249,2)
+112 ;;=^5007066
+113 ;;^UTILITY(U,$J,358.3,41250,0)
+114 ;;=I13.0^^152^2031^8
+115 ;;^UTILITY(U,$J,358.3,41250,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,41250,1,3,0)
+118 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
+119 ;;^UTILITY(U,$J,358.3,41250,1,4,0)
+120 ;;=4^I13.0
